Hyderabad Telangana, India

Naveen Krishna Yalamanchalli

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Natco Pharma Limited. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Naveen Krishna Yalamanchalli. Retrieved from https://idiyas.com/inventor/naveen-krishna-yalamanchalli

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Naveen Krishna Yalamanchalli

Introduction

Naveen Krishna Yalamanchalli is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals, particularly with his innovative work on pomalidomide.

Latest Patents

Naveen holds a patent for pharmaceutical compositions of pomalidomide. This invention relates to compositions that comprise pomalidomide and a binder or filler, with the amount of pomalidomide being at most 89% weight percent of the total weight of the composition. The process for the preparation of such compositions is also included in his patent.

Career Highlights

Naveen is currently employed at Natco Pharma Limited, where he continues to work on advancements in pharmaceutical formulations. His expertise in this area has positioned him as a valuable asset to the company.

Collaborations

Some of his coworkers include Venkaiah Chowdary Nannapaneni and Satyanarayana Vattikuti, who contribute to the innovative environment at Natco Pharma Limited.

Conclusion

Naveen Krishna Yalamanchalli's work exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, particularly in the development of pomalidomide compositions, highlight the importance of research and development in improving healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…